Belgium launches regulatory push for Advanced Therapy Medicinal Products
08-04-2025
EURACTIV - Belgium has set 2028 targets for Advanced Therapy Medicinal Products (ATMP) readiness, with the Federal Agency for Medicines and Health Products (FAMHP) launching a dedicated spearhead domain to support ATMP development. Read more
Most trials remain in early phases, and the hospital exemption route is underused due to legal uncertainty and reimbursement hurdles.